ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $512,000 | -95.8% | 9,569 | -96.2% | 0.01% | -93.9% |
| Q2 2020 | $12,219,000 | +2522.1% | 252,100 | +2216.5% | 0.21% | +2928.6% |
| Q4 2019 | $466,000 | -32.1% | 10,883 | -57.6% | 0.01% | -41.7% |
| Q2 2019 | $686,000 | -39.9% | 25,673 | -39.6% | 0.01% | -57.1% |
| Q1 2019 | $1,142,000 | +150.4% | 42,527 | +50.9% | 0.03% | +100.0% |
| Q4 2018 | $456,000 | -33.5% | 28,188 | +54.9% | 0.01% | +55.6% |
| Q3 2017 | $686,000 | -5.5% | 18,200 | -13.8% | 0.01% | 0.0% |
| Q1 2017 | $726,000 | -20.3% | 21,125 | -26.2% | 0.01% | -18.2% |
| Q3 2016 | $911,000 | -79.9% | 28,636 | -79.5% | 0.01% | -78.0% |
| Q2 2016 | $4,524,000 | +1875.5% | 139,382 | +2061.3% | 0.05% | +733.3% |
| Q4 2015 | $229,000 | -26.1% | 6,449 | -12.9% | 0.01% | 0.0% |
| Q2 2015 | $310,000 | +7.6% | 7,400 | -36.5% | 0.01% | -53.8% |
| Q3 2014 | $288,000 | -47.6% | 11,650 | -52.1% | 0.01% | -43.5% |
| Q2 2014 | $550,000 | – | 24,329 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |